Nuo Therapeutics Debt-to-Assets Ratio Growth & History (AURX)

Nuo Therapeutics's debt-to-assets ratio was 0.05 for fiscal 2025.

View full Nuo Therapeutics company overview

Nuo Therapeutics annual debt-to-assets ratio history

Nuo Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.05−0.09−61.79%
20242024-12-310.140.00+1.42%
20232023-12-310.140.03+23.79%
20222022-12-310.110.11
20212021-12-310.000.00
20202020-12-310.00−1.48
20192019-12-311.481.17+368.02%
20182018-12-310.320.32
20172017-12-310.000.00
20162016-12-310.000.00
20152015-12-310.00−0.01
20142014-12-310.010.00+32.15%
20132013-12-310.00−0.01−58.03%
20122012-12-310.01−0.01−52.89%
20112011-12-310.02

Nuo Therapeutics debt-to-assets ratio trends

Over the last five fiscal years, Nuo Therapeutics's debt-to-assets ratio increased from 0.00 to 0.05, a change of 0.05. The latest reported quarter, Q2 2026, shows 0.02.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nuo Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about AURX yet. Start the conversation.

Write the first post